JWTH: AI that looks at cells and the big picture to find biomarkers
Most pathology AIs read slides patch by patch, often missing the subtle shapes of individual cells. JWTH (Joint-Weighted Token Hierarchy) changes that by fusing cell-level clues with whole-tissue context in one foundation model.
- What’s new: a cell-centric post-tuning step and attention pooling that combine local and global tokens.
- Why it matters: infer molecular biomarkers directly from standard H&E slides, making results more interpretable and robust.
- How it performed: across four biomarkers and eight patient cohorts, JWTH reached up to 8.3% higher balanced accuracy and a 1.2% average gain over prior pathology foundation models.
- Under the hood: large-scale self-supervised pretraining, then joint weighting to merge cell and tissue signals.
This brings AI-assisted biomarker detection closer to real-world pathology workflows.
By Jingsong Liu, Han Li, Nassir Navab, and Peter J. Schüffler. Read more: http://arxiv.org/abs/2511.05150v1
Paper: http://arxiv.org/abs/2511.05150v1
Register: https://www.AiFeta.com
#AI #DigitalPathology #Biomarkers #Cancer #MachineLearning #Healthcare #ExplainableAI
